الابراهيمي يرد على خبراء كذبوا تصريحاته

الإبراهيمي كذاب و سيماهم على وجوههم أنا ااكد أن الأطفال لا ينقلون العدوى من خلال تجربتي مع أطفالي فأطفالنا ينامون معنا في فراش واحد و لا ينقلون لنا أي عدوى و الإبراهيمي حمال حطب جهنم يقول أنهم ينقلونها بالرغم أنهم لا يحتكون في المدرسة و كل تلميذ في طاولة
المناعة الجماعية مستحيلة مع فيروس يتمحور مثل كوفيد19 مثل اللقاح السنوي الخاص بالزكام و الذي يستعمل منذ عدة سنوات فهو أيضا لا يعطي مناعة جماعية و يجب أخذه كل سنة و هم يكذبون عليكم بالمناعة و سيظلون يلقحونكم إلى أن تلقوا خالقكم إذا لم تستيقظوا من الغفلة

ايوا فين بوخنونة الذي كذب كل شيء.. اقرأ ذلك التقرير ايها الحقبر المغاربة راهم سيادك وقادرين يحميو بلادهم من الطفيليات امثال اؤلاذك المعلقين الذين يهاجمون الابراهمي وغيره والكل يعرفهم ويعرف اسباب حقدهم.

ان ام تكن تابع لمادا اي قرار اتخدته فرنسا مند اندلاع حرب الفيروس تصبحه في المغرب سدات فرنسا المغرب سد لقحات فرنسا دازت سن 12 و 17 طلقات

واش نت سميتي راسك كفاءة والله إلى ضحكتي علينا البراني .ماشي غير الخبراء ديال فرنسا لقالو ديك الكلام حتى الخبراء الألمان والبطانيين قالو نفس الكلام كولشي هاذ الخبراء معرفينش غير نت لعارف إوا قولينا بعد غير منين جانا الفيروس واش صناعة بشرية أم من الخفافيش؟ مازال مكين الجواب على هذا السؤال أوليدي هذا أشي كبير عليك بزاف أوليدي سير الخويا سير متبقاش دير ضحك فراسك

البروفيسور عز الدين الإبراهيمي لديه الحق وهذه الدراسة المتأخرة من جامعة هارفارد

Which COVID-19 vaccines has the FDA authorized for children?
In December 2021, the FDA authorized, and the CDC recommended, a single-dose Pfizer/BioNTech COVID-19 booster shot for 16- and 17-year-olds, at least six months after getting their second dose of that vaccine.

As of November 2021, the FDA has authorized, and the CDC has recommended, that children ages 5 to 17 years receive a Pfizer/BioNTech COVID-19 vaccine. Children 12 to 17 years may be vaccinated with the standard Pfizer/BioNTech vaccine, while children ages 5 to 11 years should receive Pfizer/BioNTech’s pediatric vaccine, which is a lower dose (10 micrograms compared to 30 micrograms for people 12 year and older). For now, only the Pfizer/BioNTech vaccine is authorized in the US for anyone under age 18.

I have been hearing about heart problems in kids and young adults following the COVID vaccine. Should I still get my child vaccinated?
There has a been a higher-than-expected number of heart inflammation cases after vaccination with the mRNA COVID-19 vaccines, particularly among boys and young men. However, the CDC still strongly recommends that all children 12 years and older be vaccinated.

As of July 12, 2021, 1,047 reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer lining of the heart) had been reported in people under age 30, particularly in male teens and young adults, after vaccination with the Pfizer/BioNTech or Moderna mRNA vaccines The CDC’s Advisory Committee on Immunization Practices (ACIP) has said available data “suggest likely association of myocarditis with mRNA vaccination in adolescents and young adults.” Even with the increased risk, heart inflammation is a rare occurrence.

Myocarditis and pericarditis after vaccination was most common in males ages 16 to 24. Cases tended to occur within several days after the second mRNA vaccine dose. Most people who developed myocarditis or pericarditis had mild cases and recovered completely after treatment.

If your child develops any of the following symptoms within a week of vaccination, seek medical care:

chest pain
shortness of breath
feeling like your heart is beating fast, fluttering, or pounding.
This or any other potential significant side effect of a vaccine is always of special concern in children. While the risk of COVID causing severe illness and hospitalization is much lower compared to adults, it’s important to remember that at least 491 children ages 0 to 17 years have died from COVID. In addition, long-term adverse health effects even after mild infection in children are now being recognized.

It’s understandable that many parents will be uncomfortable with either choice, vaccinate now or wait. But the rise of the more contagious and possibly more dangerous Delta variant, combined with the protection offered by herd immunity, supports the CDC recommendation that all children ages 12 year and older get vaccinated.

How does COVID-19 affect children?
Children, including very young children, can develop COVID-19. Many of them have no symptoms. Those that do get sick tend to experience milder symptoms such as low-grade fever, fatigue, and cough. Some children have had severe complications, but this has been less common. Children with underlying health conditions may be at increased risk for severe illness.

A potentially severe and dangerous complication can occur in children. Called multisystem inflammatory syndrome in children (MIS-C), it can lead to life-threatening problems with the heart and other organs in the body. In this condition, different body parts, such as the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs, can become inflamed.

Symptoms of MIS-C can include

fever lasting more than a couple of days
rash
“bloodshot eyes”(redness of the white part of the eye)
stomachache
vomiting and/or diarrhea
a large, swollen lymph node in the neck
neck pain
red, cracked lips
a tongue that is redder than usual and looks like a strawberry
swollen hands and/or feet
irritability and/or unusual sleepiness or weakness.
Many conditions can cause symptoms similar to those of MIS-C. Your doctor will first want to know if your child has been around someone who has tested positive for the virus and will ask about all of the above symptoms. Results of the physical examination, a COVID-19 diagnostic or blood antibody test, and other medical tests that check for inflammation and how organs are functioning can support the diagnosis of MIS-C.

Call the doctor if your child develops symptoms, particularly if their fever lasts for more than a couple of days. If the symptoms get any worse or just don’t improve, call again or bring your child to an emergency room.

Doctors have had success using various treatments for inflammation, as well as treatments to support organ systems that are having trouble. While there have been some deaths, most children who have developed MIS-C have recovered.

The journal Lancet Child & Adolescent Health published a study that looked at the long-term health effects of MIS-C on 46 children hospitalized with MIS-C between April and September 2020. All of the children had systemic inflammation; most also had problems related to gastrointestinal, heart, and kidney function, and clot formation. By six months after the children were discharged from the hospital, most of these problems had resolved, without lasting organ damage in most cases. About one-third of the children continued to have muscle weakness, fatigue, and mental health difficulties. But the study could not determine whether these effects were due to MIS-C in particular, or to hospitalization, or other factors.

When will children be able to get the COVID-19 vaccine?
In December 2021, the FDA authorized, and the CDC recommended, a single-dose Pfizer/BioNTech COVID-19 booster shot for 16- and 17-year-olds, at least six months after getting their second dose of that vaccine.

In November 2021, the CDC recommended that children 5 to 11 years old be vaccinated with the Pfizer/BioNTech pediatric COVID-19 vaccine. The recommendation followed the FDA’s authorization of the vaccine for children in this age group.

As with older children and adults, 5-to-11-year-olds will need two doses of the Pfizer/BioNTech vaccine, spaced three weeks apart. But they will receive a lower dose (10 micrograms) compared to 30 micrograms for people 12 year and older.

In study data submitted by Pfizer to the FDA, 2,268 children, ages 5 to 11, received two 10-microgram doses of the COVID-19 vaccine, spaced three weeks apart, while a smaller group of children received a placebo. Antibody responses and side effects in the 5-to-11-year-olds were comparable to those of 16-to 25-year-old participants from a previous study.

A subsequent analysis compared COVID-19 infections in the vaccine and placebo groups. It found the Pfizer vaccine to be 90.7% effective at protecting against COVID-19 infection, compared to placebo. This was based on three cases of COVID-19 in vaccinated study participants, compared to 16 cases in the placebo group. There were no cases of severe COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in either group during the study.

When making their decisions, both the FDA and CDC considered the benefits of the vaccine, the risks of COVID-19, and the risks associated with mRNA vaccines, particularly rare side effects such as the heart inflammation that has been seen after mRNA vaccination, especially in male adolescents and young adults. Ultimately, they decided that the benefits of the vaccine outweigh the possible risks, but will continue to monitor safety data.

In May 2021, the FDA had expanded its EUA for the Pfizer/BioNTech COVID-19 vaccine to include adolescents 12 to 15 years old in May 2021. Previously, the Pfizer vaccine was authorized for use in children 16 years and older. A CDC report published in MMWR in October 2021 showed that 12- to 18-year-olds who’d gotten two doses of the Pfizer vaccine were 93% less likely than those who were unvaccinated to be hospitalized for COVID-19. COVID-related hospitalizations in children and adolescents are still relatively rare; the majority of participants in this study had at least one underlying medical condition that put them at increased risk for severe illness.

The Moderna and Johnson & Johnson vaccines are currently authorized for people 18 years and older. In June 2021, Moderna applied to the FDA for emergency use authorization (EUA) of their mRNA vaccine for use in children ages 12 to under 18 years. The FDA is continuing to evaluate safety data about the risk of myocarditis after vaccination, and recently notified the company that it may not complete its review until early 2022. Moderna announced promising results of a Phase 2/3 study in adolescents in May. The study enrolled 3,732 children ages 12 to 17. Two-thirds received two doses of the Moderna mRNA vaccine and one-third received a placebo. The immune response generated by the vaccine in adolescents was found to be at least as good as the immune response the vaccine generated in adults. Starting two weeks after the second vaccine dose, no cases of COVID-19 occurred in the vaccine group, compared to four cases in the placebo group. Vaccine side effects were mild to moderate, with injection site pain, headache, fatigue, muscle pain, and chills being the most common. The study did not identify any significant safety concerns. The results were announced in a press release.

In October 2021, Moderna released an interim analysis of their phase 2/3 study in children. For this part of the randomized, observer-blind, placebo-controlled trial, researchers enrolled 4,753 children ages 6 years to under 12 years of age. The children received either two doses of the Moderna vaccine, spaced 28 days apart, or two doses of placebo. The vaccine dose was 50 micrograms, which is lower than the 100-microgram dose authorized for adults, but the same as the dose recently authorized for the Moderna booster. One month after receiving their second dose, the vaccinated children in this study had antibody levels that were about 1.5 times higher than those seen in young adults after two 100-microgram vaccine doses. Most side effects were mild to moderate, and included fatigue, headache, fever, and pain at the injection site. The study was too small to measure rare side effects. The analysis was announced in a press release and has not been published or peer reviewed. Moderna will submit these results to the FDA, and is also studying their vaccine in children between the ages of 6 months and 6 years.

Age de-escalation studies, in which the vaccines are tested in groups of children of descending age, are done to confirm that the vaccines are safe and effective for each age group. They also identify the optimal dose, which must be effective, but with tolerable side effects.

The FDA reviews data from the de-escalation trials to decide whether to authorize the vaccines for each age group. The CDC then considers whether to issue a recommendation.

Who could benefit from monoclonal antibody therapy to prevent COVID-19?
Vaccines are the best way to protect against COVID-19. But some people with weakened immune systems do not produce enough antibodies after vaccination, and others are severely allergic to the vaccine. The FDA recently authorized Evusheld, a pre-exposure prophylaxis (PrEP) monoclonal antibody therapy developed by AstraZeneca, which should help prevent COVID-19 in these populations.

To be eligible for Evusheld, individuals must be 12 years or older and have a moderately to severely weakened immune system, or have a history of severe adverse reactions to the COVID-19 vaccine or its components. In addition, the therapy cannot be given to someone with a current SARS-CoV-2 infection, or who has been recently exposed to someone who is infected. Evusheld is given as two consecutive shots, and evidence suggests it can help prevent symptomatic infection for at least six months.

Monoclonal antibodies are manmade versions of the antibodies that our bodies naturally make to fight invaders, such as the SARS-CoV-2 virus. The monoclonal antibodies in Evusheld, tixagevimab and cilgavimab, are directed against the virus’s spike protein and are designed to block the virus from attaching to, and entering, human cells.

When considering authorization, the FDA looked at results from the PROVENT trial. This was a randomized, double-blind, placebo-controlled clinical trial that enrolled adults ages 59 years and older, people with certain chronic medical conditions, and those who were at increased risk of infection for other reasons and had not gotten a COVID-19 vaccine. None of the participants had a current or previous case of SARS-CoV-2 infection. 3,441 study participants received Evusheld and 1,731 received a placebo.

Study participants who’d received Evusheld were 83% less likely to have had symptomatic COVID-19 during the six-month study period than those who had a received a placebo. This was a statistically significant difference. Researchers are looking at how well Evusheld will protect against the Omicron variant.

Possible side effects of this therapy including allergic reactions, bleeding at the injection site, headache, fatigue, and cough. In addition, although serious heart-related events such as heart attack and heart failure were infrequent during the trial, they were more common in participants who received Evusheld than in those who received a placebo.

Unlike other monoclonal antibody treatments that have been authorized by the FDA, Evusheld is not authorized to treat an active COVID-19 infection or to prevent infection after exposure to the virus.

What needs to happen for schools to open safely?
School closures have impacted children on many fronts, from academics and social interaction to equity, food security, and mental health. Safely returning children to in-person instruction in fall 2021 is a priority for the CDC.

In July 2021, the CDC recommended that all teachers, staff, students, and visitors to schools wear masks while indoors, regardless of whether or not they are vaccinated. They also recommend that everyone who is eligible for vaccination get the vaccine.

There are several other prevention strategies that, when layered together, should minimize the spread of COVID-19 in schools. These include physical distancing; screening, testing, and contact tracing; staying home when sick; and frequent handwashing. Schools should also do their best to improve ventilation, by opening windows and doors, for example. Decisions about some of these prevention strategies may depend on levels of community transmission.

Are kids any more or less likely than adults to spread coronavirus?
Most children who become infected with the COVID-19 virus have no symptoms, or they have milder symptoms such as low-grade fever, fatigue, and cough. Early studies suggested that children do not contribute much to the spread of coronavirus. But more recent studies indicate that children are capable of spreading the infection.

Though the studies varied in their methods, their findings were similar: infected children had as much, or more, coronavirus in their upper respiratory tracts as infected adults. And a November 2021 study conducted by Harvard researchers again confirmed that children carry live virus capable of infecting others.

The amount of virus found in children — their viral load — was not correlated with the severity of their symptoms. In other words, a child with mild or no symptoms may have just as many viral particles in their nose and mouth as a child that has more severe symptoms. So, the presence of a high viral load in infected children increases the likelihood that children, even those without symptoms, could readily spread the infection to others.

The bottom line? Public health measures are as important for kids and teens as they are for adults.

Should parents take babies for initial vaccines right now? What about toddlers and up who are due for the standard vaccines?
Getting early immunizations in for babies and toddlers — especially babies 6 months and younger — has important benefits. It helps to protect them from infections such as pneumococcus and pertussis that can be deadly, at a time when their immune system is vulnerable.

Now that doctors’ offices and clinics have taken specific measures to prevent COVID-19 spread, vaccinations for children don’t need to be delayed. That’s especially true for children with special conditions.

However, if you are concerned about going to an office or clinic, it’s best to call and let them know how you feel. Find out what precautions they are taking to keep children safe, and discuss your particular situation, including not only your child’s health situation, but also the prevalence of the virus in your community and whether you have been or might have been exposed. Together, you can make the best decision for your child.

When do you need to bring your child to the doctor during this pandemic?
If you have any concerns about your child, call your doctor’s office for advice. Many practices are offering phone or telemedicine visits, and it’s remarkable how many things can be addressed that way.

Some things, though, may require an in-person appointment, including:

Illness or injury that could be serious, such as a child with trouble breathing, significant pain, unusual sleepiness, a high fever that won’t come down, or a cut that may need stitches or a bone that may be broken. Call your doctor for guidance as to whether you should bring your child to the office or a local emergency room.
Children who are receiving ongoing treatments for a serious medical condition such as cancer, kidney disease, or a rheumatologic disease. These might include chemotherapy, infusions of other medications, dialysis, or transfusions. Your doctor will advise you about any changes in treatments or how they are to be given during the pandemic. Do not skip any appointments unless your doctor tells you to do so.
Checkups for very young children who need vaccines and to have their growth checked. Check with your doctor regarding their current policies and practices.
Checkups and visits for children with certain health conditions. This might include children with breathing problems whose lungs need to be listened to, children who need vaccinations to protect their immune system, children whose blood pressure is too high, children who aren’t gaining weight, children who need stitches out or a cast off, or children with abnormal blood tests that need rechecking. If your child is being followed for a medical problem, call your doctor for advice. Together you can figure out when and how your child should be seen.
Bottom line: Talk to your doctor. The decision will depend on a combination of factors including your child’s condition, how prevalent the virus is in your community, whether you have had any exposures or possible exposures, what safeguards your doctor has put into place, and how you would get to the doctor.

I am pregnant and plan to eventually breastfeed my baby. Is it safe for me to get a COVID-19 vaccine?
In September 2021, the CDC “strongly recommended” that women who are pregnant, thinking about becoming pregnant, or were recently pregnant, including those who are breastfeeding, should get vaccinated against COVID-19. The American College of Obstetrics and Gynecology (ACOG) and the Society for Maternal-Fetal Medicine also agree that all pregnant and breastfeeding individuals should be vaccinated.

The World Health Organization (WHO) recommends use of a COVID-19 vaccine in pregnant women when the benefit to an individual outweighs the potential vaccine risks. Experts, including the WHO, believe it is most likely safe to get a COVID-19 vaccine if you’re breastfeeding. Similar to any decision regarding over-the-counter medications and supplements during pregnancy, your own doctor is in the best position to advise you based on your personal health risks and preferences.

Here are some factors to consider. First, although the actual risk of severe COVID-19 illness and death among pregnant individuals is very low, it is higher when compared to nonpregnant individuals from the same age group. In addition, COVID-19 increases risk for premature birth, and possibly also for other undesirable pregnancy outcomes. Transmission of the virus from mother to baby during pregnancy is possible, but it appears to be a rare event.

The CDC’s stronger recommendation followed safety data released in August 2021. The study enrolled nearly 2,500 women who received a COVID-19 vaccine, either before becoming pregnant or during their first 20 weeks of pregnancy, and found that they did not have an increased risk of miscarriage.

A previous study, conducted by the CDC and published in NEJM, found the COVID-19 vaccines to be safe when given during the second or third trimester.

Another small study, which compared vaccine efficacy in pregnant and nonpregnant women, was published in the American Journal of Obstetrics and Gynecology. The study found that mRNA vaccines effectively produce antibodies that protect against SARS-CoV-2 in women who are pregnant or breastfeeding, and that this immunity is passed from mother to newborn through the placenta and breast milk.

mRNA vaccines do not contain any virus, so they cannot cause COVID-19 in a woman or her baby. And our bodies quickly break down and eliminate mRNA particles used in the vaccine, so they cannot reach or cross the placenta.

Is it okay to have babysitters or child care people in the house given no know exposures or illness in their homes?
The truth is that the fewer people you and your children are exposed to, the better. However, the reality is that not every family will be able to have a parent at home at all times.

All people can do is try to minimize the risk by doing things like:

choosing a babysitter who has minimal exposures to other people besides your family
limiting the number of babysitters. If you can keep it to one, that’s ideal, but if not keep the number as low as possible
making sure that the babysitter understands that he or she needs to practice physical distancing, and needs to let you know (and not come to your house!) if he or she feels at all sick or has a known exposure to COVID-19
having the babysitter limit physical interactions and closeness with your children, to the extent that this is possible
making sure that everyone washes their hands frequently throughout the day, especially before eating.
Can you provide some guidance regarding play dates? My kids really miss their friends.
With infection rates still high in much of the country, it’s best to minimize playdates, or to limit them to a couple of children or families with whom you have been socializing during the pandemic.

Outdoor play dates, where you can create more physical distance, is a better option than indoor playdates. Something like going for a bike ride, or a hike, allows you to be together while sharing fewer germs (bringing and using hand sanitizer is still a good idea). You need to have ground rules, though, about distance and touching, and if you don’t think it’s realistic that your children will follow those rules, then don’t do the play date even if it is outdoors.

You can still go for family hikes or bike rides where you’re around to enforce social distancing rules. Family soccer games, cornhole, or badminton in the backyard are also fun ways to get outside.

You can also do virtual play dates, using a platform like FaceTime or Skype so children can interact and play without being in the same room.

ما لا يعرفه العديد من المغاربة هو ان الإبراهيمي ليس طبيبا رغم انه يدرس في كلية الطب اي انه لم يفحص اي انسان في حياته لكنه يتكلم بينما أصحاب الاختصاص في المغرب ولاد البلاد بعيدون عن الاضواء يشتغلون في صمت. لقد تم حشو اللجنة العلمية بأشخاص لا علاقة لهم بالجائحة تماما كبرلمان” ايت منا” اللي فيه العربية زوينة وفنة…..الحاصول ما بقا ما تسنا ولا ما تمنا حريرتنا حريرة بها الشيخة تتغنا…

اسي كوريط اشمن كفائة عندك والوا انت غير داوي خاوي اشك في انه لديك شهادات علمية امكن راك غير داخل المهنة بسنطيحة وعطينا بتساع انت ومعلوماتك الكاذبة

هادوك لي تايعاكسوا فكارك اصلا ابناء البورجوازية لي قراو في فرنسا ايام كان المغرب يالله تحرر من الاستعمار واستافدوا وبما ان اليوم ابناء الشعب اصبحوا ايضا دكاترة ماعاجبعمش الحال بغاو يحتاكروها عم وفرنسا فقط